In this comprehensive systematic review of randomized controlled trials, which included a total number of 471 patients, torsemide significantly reduced HF and CV-related hospital readmissions compared ...
Researchers headed by teams at Michigan Medicine and Mayo Clinic have discovered how a molecular process that occurs when donor hearts are preserved in cold storage contributes to failure after ...
The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than ...
Future Cardiol. 2012;8(5):707-728. These data come from reports of ototoxicity of 6.4% with furosemide compared with 1 and <1% for bumetanide and torsemide, respectively. [38] Acute kidney failure is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback